Analysis updated on Nov. 6, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Our AI scores Qt Imaging Holdings, Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
Qt Imaging Holdings, Inc. is a small-cap company with a market capitalization of $30M. It ranks number 21 by market capitalization among the 29 Electromedical & Electrotherapeutic Apparatus issuers in our coverage with a current forecast. Its ROE of -909.2% is the lowest of the 16 peers that report one. Its D/E Ratio of 12.64x is the highest of the 24 peers that report one.
For QTI, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -23.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -32.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, QTI included.
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Electromedical & Electrotherapeutic Apparatus peers listed below that report each metric.
| Metric | QTI | Rank |
|---|---|---|
| Market Cap | $30M | 21/29 |
| P/B Ratio | 13.49x | 2/23 |
| EPS | $-2.62 | – |
| Book Value/Share | $0.15 | – |
| Revenue/Share | $1.81 | – |
| FCF/Share | $-0.87 | – |
| Metric | QTI | Rank |
|---|---|---|
| ROE | -909.2% | 16/16 |
| ROA | -66.7% | 15/19 |
| ROIC | -31.1% | 14/21 |
| Gross Margin | 40.4% | 22/26 |
| Operating Margin | -24.8% | 14/26 |
| Net Margin | -77.3% | 14/18 |
| EBT Margin | -111.5% | 19/26 |
| Tax Rate | 0.0% | – |
| Metric | QTI | Rank |
|---|---|---|
| Current Ratio | 3.10x | 12/28 |
| Quick Ratio | 2.06x | 13/27 |
| D/E Ratio | 12.64x | 1/24 |
| Financial Leverage | 13.64x | 1/24 |
| Interest Coverage | -1.8x | 11/28 |
| Working Capital | $20M | 14/27 |
| Metric | QTI | Rank |
|---|---|---|
| Operating Cash Flow | -$12M | 21/28 |
| Free Cash Flow | -$13M | 8/14 |
| Capital Spending | -$270K | 4/14 |
| FCF/Sales | -48.2% | 9/14 |
| CapEx/Sales | 1.0% | 9/14 |
| Metric | QTI | Rank |
|---|---|---|
| Asset Turnover | 0.86x | 7/18 |
| Receivables Turnover | 3.6x | 18/20 |
| Inventory Turnover | 1.6x | 16/26 |
| Fixed Assets Turnover | 33.3x | 8/20 |
| Days Sales Outstanding | 102 days | 3/20 |
| Days Inventory | 229 days | 11/26 |
| Payables Period | 70 days | 14/24 |
| Cash Conversion Cycle | 261 days | 3/19 |
| Metric | QTI | Rank |
|---|---|---|
| Total Revenue | $26M | 14/19 |
| Operating Income | -$7M | 16/28 |
| Net Income | -$20M | 17/20 |
| R&D Expense | $6M | 15/27 |
| SG&A Expense | $12M | 17/25 |
| Cost of Goods Sold | $16M | 14/26 |
| Metric | QTI | Rank |
|---|---|---|
| Shares Outstanding | 15M | – |
| Total Current Assets | $29M | 96.1% of assets |
| Cash & Short-term Investments | $11M | 35.7% of assets |
| Accounts Receivable | $7M | 24.2% of assets |
| Inventory | $10M | 32.2% of assets |
| Total Liabilities | $28M | 92.7% of assets |
| Short-term Debt | $6M | 21.2% of assets |
Companies classified under the same SEC industry code as Qt Imaging Holdings, Inc. (Electromedical & Electrotherapeutic Apparatus): 30 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| QTI Qt Imaging Holdings, Inc. | $30M | |
| MDT Medtronic Plc | $134.10B | |
| LIVN Livanova Plc | $4.96B | |
| ITGR Integer Holdings Corp | $4.30B | |
| AXGN Axogen, Inc. | $2.99B | |
| TMDX Transmedics Group, Inc. | $2.39B | |
| CNMD Conmed Corp | $1.53B | |
| CBLL Ceribell, Inc. | $1.02B | |
| INMD Inmode Ltd. | $766M | |
| CV Capsovision, Inc | $310M | |
| ELMD Electromed, Inc. | $227M | |
| FOCL Edap Tms Sa | $125M | |
| STXS Stereotaxis, Inc. | $109M | |
| VANI Vivani Medical, Inc. | $94M | |
| OM Outset Medical, Inc. | $77M | |
| NRXS Neuraxis, Inc | $77M | |
| HYPR Hyperfine, Inc. | $73M | |
| ECOR Electrocore, Inc. | $65M | |
| POCI Precision Optics Corporation, Inc. | $54M | |
| POSC Positron Corp | $54M | |
| VASO Vaso Corp | $51M | |
| ITOC Itonic Holdings Ltd | $12M | |
| IRIX Iridex Corp | $12M | |
| GTHP Guided Therapeutics Inc | $10M | |
| NDRA Endra Life Sciences Inc. | $8M | |
| ADMT Adm Tronics Unlimited, Inc. | $6M | |
| NUWE Nuwellis, Inc. | $2M | |
| ESMC Escalon Medical Corp | $1M | |
| NXL Nexalin Technology, Inc. | $1M | |
| YBGJ Yubo International Biotech Ltd | N/A |
Welcome to the QT Imaging Fourth Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please also note, today's event is being recorded. At this time, I would like to turn the floor ...
QT Imaging Holdings Inc (QTIH) reported a significant increase in revenue, reaching $4.2 million in Q3 2025 compared to $956,000 in Q3 2024. The company shipped 9 scanners in Q3 2025, a substantial ...
QT Imaging Holdings, Inc.(Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming ...
Our AI scores Qt Imaging Holdings, Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
For QTI, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -23.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -32.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Qt Imaging Holdings, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.
30 issuers in our coverage, QTI included, share the SEC industry code Electromedical & Electrotherapeutic Apparatus. The largest are: Medtronic Plc (MDT), Livanova Plc (LIVN), Integer Holdings Corp (ITGR), Axogen, Inc. (AXGN), Transmedics Group, Inc. (TMDX), Conmed Corp (CNMD).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.
